Emergent Biosolutions El-Hibri
June 22nd, 2009
No comments
Fuad El-Hibri has filed an intention with the SEC to sell 1.1 million shares of stock:
On January 20, 2009, Emergent Biosolutions announces that Fuad El-Hibri has filed an intention with the SEC to sell 1.1 million shares of stock: 13.5 million shares had been issued to date with 47% controlled by Fuad El-Hibri. It also announced Stage II testing of vaccines for Typhoid, Hepatitis B, and Tuberculosis.
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=75ae6421-5854-4dce-ad97-7270e741e59c)
Categories: Answer.com, BioThrax, El-Hibri Foundation, El-Hibri Peace Education, El-Hibri Peace Education Prize, Emergent BioSolutions, Entrepreneur of the Year, Fuad El-Hibri, Fuad Elhibri, Ibrahim Y. El-Hibri, Profits and Losses, Shareholders, Tuberculosis Vaccine, W. James Jackson, Washington DC, Washington Gala Conditions and Diseases, Emergent BioSolutions, Health, Hepatitis, Hepatitis B virus, SEC, Stock, U.S. Securities and Exchange Commission, Vaccine
Recent Comments